from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2392/cysH

LFCtreatmentdescriptionclass of inhibitor

-1.400

Amikacinug/mL Amikacintranslation

-1.497

Cap5-10ug/mL Capreomycintranslation

-1.515

Rox10-50 ug/mL Roxithromycintranslation

0.423

SM2-5 ug/mL Streptomycintranslation

-0.863

Tet5-10 ug/mL Tetracyclinetranslation

-0.512

Rif0.2-5ug/mL Rifampicintranscription

0.869

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.900

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.526

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.271

CPZ10-50 ug/mL Chlorpromazinerespiration

0.040

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.319

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.072

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.332

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.739

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.687

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.612

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.488

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.174

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.764

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.017

KCN5-20 ug/mL Potassium cyaniderespiration

-1.196

NaN30.2-2 mM Sodium aziderespiration

-0.425

Nigericin50 uM Nigericinrespiration

-0.762

TRC10-150 ug/mL Triclosanrespiration

-0.150

TRZ10-25 ug/mL Thioridazinerespiration

-0.180

Valinomycin0.5-10 uM Valinomycinrespiration

0.947

ZnSO42 mM ZnSO4respiration

2.486

menadione6-10 ug/mL Menadionerespiration

0.279

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.042

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.738

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.269

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.065

NRP_1Non-replicating persistence stage 1dosRassociated

0.420

Amp0.2mg/mL AmpicillincellWall

0.500

Cephalexin20-100 ug/mL CephalexincellWall

-1.199

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.301

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.319

EMB10-20 ug/mL EthambutolcellWall

0.222

Eta12-40 ug/mL EthionamidecellWall

0.261

INH0.2-0.4 ug/mL IsoniazidcellWall

0.522

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.268

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.080

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.104

BZA0.12 mg/mL BenzamidearomaticAmides

-0.203

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.285

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.019

H2O24 mM hydrogen peroxideDNAdamaging

1.010

Levo10 ug/mL LevofloxacinDNAdamaging

-0.239

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.997

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.410

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.528

UVUV-irradiationDNAdamaging

1.212

ARP41-4 ug/mL Antitubercular compound ARP4?

0.029

Antimycin12.5-50 ug/mL Antimycin A?

0.413

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.397

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.089

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.706

PA8240.2-2 ug/mL PA-824?

-0.431

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.569

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.093

Verapamil50 uM Verapamil?

0.797

mercaptoethanol2 mM 2-Mercaptoethanol?

0.055

methoxatin10-20 ug/mL Methoxatin?